Abstract
During early obesity, pancreatic β cells compensate for increased metabolic demand through a transient phase of insulin hypersecretion that stabilizes blood glucose and forestalls diabetic progression. We find evidence that β cell O-GlcNAcylation, a nutrient-responsive post-translational protein modification regulated by O-GlcNAc transferase (OGT), is critical for coupling hyperlipidemia to β cell functional adaptation during this compensatory prediabetic phase. In mice, islet O-GlcNAcylation rises and falls in tandem with the timeline of secretory potentiation during high-fat feeding while genetic models of β-cell-specific OGT loss abolish hyperinsulinemic responses to lipids, in vivo and in vitro. We identify the endoplasmic reticulum (ER) Ca2+ ATPase SERCA2 as a β cell O-GlcNAcylated protein in mice and humans that is able to rescue palmitate-stimulated insulin secretion through pharmacological activation. This study reveals an important physiological role for β cell O-GlcNAcylation in sensing and responding to obesity, with therapeutic implications for managing the relationship between type 2 diabetes and its most common risk factor.
Original language | English (US) |
---|---|
Article number | 107609 |
Journal | Cell reports |
Volume | 31 |
Issue number | 5 |
DOIs | |
State | Published - May 5 2020 |
Bibliographical note
Publisher Copyright:© 2020 The Author(s)
Fingerprint
Dive into the research topics of 'Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2'. Together they form a unique fingerprint.Equipment
-
-
Nikon C2 Upright Spectral Confocal and Widefield Imaging System
University Imaging CentersEquipment/facility: Equipment
-
University Imaging Centers
Mark A Sanders (Program Director) & Guillermo Marques (Scientific Director)
University Imaging CentersEquipment/facility: Facility